HAEMATOCON 2026 Conference Overview

The Indian Society of Hematology and Blood Transfusion (ISHBT) will host its 67th annual conference, HAEMATOCON 2026, in Ahmedabad from November 12 to November 15, 2026. The four‑day event will be held at Club O7 and is slated to attract approximately 4,000 delegates from across India together with 200 international faculty members. International participants will include experts from the United States, United Kingdom, Germany, Australia, Japan, China and Bangladesh.

Theme and Academic Programme

The conference theme, “Advancing Hematology: From Evidence to Clinical Excellence,” will guide an academic programme covering benign and malignant haematology, transfusion medicine, stem‑cell transplantation, molecular diagnostics and laboratory haematology. The schedule will feature plenary lectures by national and international authorities, research presentations, interactive case discussions, hands‑on workshops and an exhibition showcasing the latest developments in the field. Awards will be presented for outstanding research contributions.

Key Clinical Focus Areas

Six major condition categories will be highlighted:

  • Sickle cell disease – emphasis on early screening, genetic counselling and comprehensive care.
  • Haemophilia – focus on awareness of inherited blood disorders, carrier screening and access to appropriate treatment.
  • Thalassaemia – similar emphasis on inherited disorder awareness, carrier detection and treatment pathways.
  • Anaemia – identification of underlying causes and timely medical intervention.
  • Leukaemia – discussion of advances in chemotherapy, targeted therapy, immunotherapy and bone‑marrow transplantation.
  • Immune thrombocytopenia (ITP) – recognition of low‑platelet‑count symptoms and evolving treatment options.

Statements from Organisers

Dr. Tuphan Kanti Dolai, Secretary of ISHBT, noted that recent advances have transformed diagnosis and treatment of blood disorders and underscored the need for greater public awareness about early diagnosis, prevention and treatment access. Dr. Amit Khurana, Organising Secretary of HAEMATOCON 2026, stated that the conference aims to serve as a platform for scientific exchange and broader patient‑focused engagement, highlighting how timely diagnosis can improve outcomes, encouraging voluntary blood donation, promoting stem‑cell donor registration and bridging the gap between medical advances and public understanding.

Additional Features

The conference will also include an exhibition area for industry and academic stakeholders, interactive workshops, and the presentation of awards recognizing exceptional research.

Disclaimer: The press release is provided under an arrangement with NRDPL. PTI takes no editorial responsibility for the content.